Driving the expansion of mRNA into the therapeutic sphere

The advanced therapies industry is heavily engaged in capitalizing upon the success of mRNA-based COVID-19 vaccines. Novel therapeutic applications in major disease areas, including oncology, continue to show promise in preclinical and early clinical studies, yet challenges remain. Cell & Gene Therapy Insights brought together a panel of industry experts to discuss the expanding reach of mRNA technology, exploring how and where it will impact the advanced therapies space moving forward.

Please enter your email to access content Read now